NDAINJECTIONINJECTABLE
Approved
Mar 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Mechanism of Action
12.1 Mechanism of Action Cefoxitin is an antibacterial drug [ ] . 12.2 Pharmacodynamics The pharmacodynamic properties of cefoxitin are unknown. 12.3 Pharmacokinetics Absorption Following an intravenous dose of 1 gram, serum concentrations were 110 mcg/mL at 5 minutes, declining to less than 1…
Indications (36)
lower respiratory tract infectionsincluding pneumonialung abscesscaused by Streptococcus pneumoniaeother streptococci (excluding enterococciurinary tract infections caused by Escherichia coliKlebsiella speciesProteus mirabilisMorganella morganiiProteus vulgarisProvidencia species (including Pintra-abdominal infectionsincluding peritonitisintra-abdominal abscesscaused by Escherichia coliBacteroides species including Bacteroides fragilisClostridium speciesgynecological infectionsincluding endometritispelvic cellulitispelvic inflammatory disease caused by Escherichia coliNeisseria gonorrhoeae (including penicillinase-producing strains)Bacteroides species including BSepticemia caused by Streptococcus pneumoniaeStaphylococcus aureus (including penicillinase-producing strains)Escherichia colibonejoint infections caused by Staphylococcus aureus (including penicillinase-producing strains)skinskin structure infections caused by Staphylococcus aureus (including penicillinase-producing strains)Staphylococcus epidermidisStreptococcus pyogenesinfection in patients undergoing uncontaminated gastrointestinal surgeryvaginal hysterectomyabdominal hysterectomycesarean section